Ben Lamm

Meet the North Texas Cos. on the 2023 TIME100 Most Influential List

by | Jun 21, 2023
Featuring "a diverse group of businesses helping chart an essential path forward," the TIME100 Most Influential Companies list features five companies that are either headquartered in North Texas or have a strong presence here. See who they are—and what they're doing to disrupt the status quo and innovate for the future.
MORE
Colossal Biosciences, Vertebrate Genomes Project Publish First High-Quality Reference Genome of African Elephant
by | May 19, 2023
Last year, the partnership announced a near complete sequence of the Asian elephant genome. Colossal and VGP said the sequencing work is part of a long-term effort to ensure the survival of elephant species in the face of climate change, deforestation, and disease.
MORE
Ben Lamm Hypergiant
Hypergiant Awarded Over $16M from U.S. Air Force for Cloud-Based Command and Control UX
by | May 5, 2023
Hypergiant Galactic Systems Founder and Board Member Ben Lamm—who's also the co-founder and CEO of Texas-based Colossal Biosciences—tweeted out six rocket emojis to congratulate the Hypergiant team.
MORE

Meet the Finalists: The Innovation Awards 2023, Presented by Dallas Innovates and D CEO

by | Nov 3, 2022
Now in its fourth year, the program from Dallas Innovates and D CEO honors 68 disruptors and trailblazers driving a new vision for innovation in North Texas. Finalists will be recognized in the January/February issue of D CEO magazine and online at DallasInnovates.com. Winners will be revealed at an exclusive awards event in January.
MORE
Mammoth Interest: The CIA Invests in Dallas-Based Colossal Biosciences
by | Oct 11, 2022
The Central Intelligence Agency has invested in Colossal through its nonprofit VC investment arm, In-Q-Tel, reports The Intercept. Named in honor of Q—the tech genius from the James Bond novels and movies—the VC firm was founded in 1999 to keep U.S. intelligence agencies on the cutting edge of "innovative and impactful technologies coming out of Silicon Valley and beyond." So why Colossal? "Strategically, it’s less about the mammoths and more about the capability," In-Q-Tel says.
MORE
The Last Word: Colossal’s Ben Lamm on Seeing His Startup Fuel a ‘Jeopardy’ Answer
by | Oct 3, 2022
In August, Colossal Biosciences announced it is working to "de-extinct" the Tasmanian tiger with the help of an Australian university and “marsupial biobanking.” It didn't take long for the TV show "Jeopardy" to notice—and work it into an answer.
MORE
Follow the Money: Book.io Aims to Put E-Books on the Blockchain with New Funding, Tech Startup Kalpa Aims to Raise $1M, and More
by | Sep 30, 2022
In this week’s North Texas deal flow, you’ll also find news about crowdfunding platform Harvest Return landing $2.5M; Supply’s acquisition by Foundry Brands; Moss Adams acquiring local CPA firm Kurtz & Company P.C.; Tri Global Energy being acquired for $270M by Canada's Enbridge; and more.
MORE

Dallas-Based Colossal Is ‘De-Extincting’ the Tasmanian Tiger

by | Aug 16, 2022
Colossal is already working to "de-extinct" the woolly mammoth via a mammoth-elephant hybrid project. Now the Tasmanian tiger—which went extinct nearly 100 years ago due to human hunting—is the second species Colossal is seeking to bring back. "We’re thrilled to be collaborating with Andrew Pask and the University of Melbourne to restore this amazing animal to Earth," said Ben Lamm, Colossal's co-founder and CEO.
MORE
Funding
Follow the Money: Dallas SPAC Raises $123M IPO, FortyTwo.VC Aims to Raise $50M Fund, Crestline Investors Closes Funds with $3.6B in Commitments, and More
by | Mar 21, 2022
What companies are finding funding or having a big exit? From startup investments to grants and acquisitions, Dallas Innovates tracks what’s happening in North Texas money.
MORE
Mammoth Project: Dallas’ Colossal Raises $60M to Advance Genetic Engineering and ‘De-Extinction’ Technologies
Colossal launched last September with a plan to "de-extinct" the woolly mammoth by using CRISPR genetic engineering to create a mammoth-elephant hybrid. With a total raise of $75 million to date, the startup aims to have its first set of mammoth-elephant hybrid calves "in 4 to 6 years," co-founder and CEO Ben Lamm told us. But Colossal's goals extend much further—with the potential "to advance human health, enhance food production, reduce environmental impact, and optimize animal health and welfare."
MORE

Hypergiant Industries Names Enterprise Tech Expert as CEO; Founder Ben Lamm Moves to Vice Chairman

by | May 18, 2021
Software executive Mike Betzer will lead the next phase of Hypergiant's growth, including a rollout of the industry's first system that provides open AI integration for building AI models.

Founder Ben Lamm, who launched Hypergiant from stealth in 2018, will pursue "the most pressing issues of our lifetime": AI for good, climate change, and the positive impact of technology. "This is where the world needs my time and attention," he says.
MORE
algae hypergiant industries
The Art of Climate Tech: Fort Worth Museum Showcases Hypergiant’s AI-Powered, Carbon-Capturing Eos Bioreactor
by | Nov 10, 2020
The Eos Bioreactor, which also has been featured in Popular Mechanics, uses algae to "eat" CO2.
MORE
Hypergiant Industries Brings on Former IBM General Manager Mohammed Farooq as Global CTO
by | Sep 22, 2020
Farooq will also join the Board of Directors and be the GM of Products at the Texas-based startup. The move is expected to set Hypergiant up for accelerated growth.
MORE
‘Minutes, Not Months’: Texas‑based Hypergiant Partners With United States Air Force on Satellites That Update in Real Time
by | Jun 30, 2020
A fleet of mini-satellites working together in space will update actions and tasks ‘on the fly’ based on emerging scenarios and mission needs, says CEO Ben Lamm. That’s something that’s never been done before. That ability to update, collect, and share data in space—in real time—is an evolution for defense and commercial use cases.
MORE
Protecting your privacy. We have strengthened our Privacy Policy to better protect you. This Policy includes our use of cookies to give you the best online experience and provide functionality essential to our services. By clicking ‘I Accept’ or by continuing to use our website, you are consenting to our Privacy Policy.